JONATHAN PORTER to Diketopiperazines
This is a "connection" page, showing publications JONATHAN PORTER has written about Diketopiperazines.
Connection Strength
0.110
-
Provider Factors Likely to Impact Access and Uptake of Long-Acting Injectable Cabotegravir for Transgender Women in the United States: Results of a Qualitative Study. J Assoc Nurses AIDS Care. 2024 Sep-Oct 01; 35(5):437-449.
Score: 0.055
-
Improving Recruitment and Retention of Transgender Women in HIV Prevention Trials: Strategies to Make Trial Participation More Congruent with the Needs of Transgender Women. AIDS Res Hum Retroviruses. 2024 12; 40(12):680-689.
Score: 0.055